A critical review of the Corporate Governance dimension in the Sustainability Indexes questionnaires

by Andreu Pinillos, A., Fernández-Fernández, J. L., Fernández Mateo, J.
Published 2018-09-01

A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration-Resistant Prostate Cancer*

by Wilbaux, M, Tod, M, De Bono, J, Lorente, D, Mateo, J, Freyer, G, You, B, Hénin, E
Published 2015

Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism

by Rubio-Terrés, C., Soria, J. M., Morange, P. E., Souto, J. C., Suchon, P., Mateo, J., Saut, N., Rubio-Rodríguez, D., Sala, J., Gracia, A., Pich, S., Salas, E.
Published 2015

A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors

by Mateo, J., Berlin, J., de Bono, J. S., Cohen, R. B., Keedy, V., Mugundu, G., Zhang, Lianglin, Abbattista, A., Davis, C., Gallo Stampino, C., Borghaei, H.
Published 2014

Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone

by Lorente, D, Omlin, A, Ferraldeschi, R, Pezaro, C, Perez, R, Mateo, J, Altavilla, A, Zafeirou, Z, Tunariu, N, Parker, C, Dearnaley, D, Gillessen, S, de Bono, J, Attard, G
Published 2014

Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail

by Ong, M, Carreira, S, Goodall, J, Mateo, J, Figueiredo, I, Rodrigues, D N, Perkins, G, Seed, G, Yap, T A, Attard, G, de Bono, J S
Published 2014